Jill Bell is the Chief Science Officer at Evinova. With extensive experience in health-related quality of life and patient-reported outcomes, Jill has managed numerous projects encompassing endpoint strategy development, study implementation, and dissemination. Previously, they completed a postdoctoral fellowship at Duke University and conducted impactful research on insulin resistance and obesity. Jill holds a Ph.D. from the University of Southern California and has published extensively in peer-reviewed journals throughout their career.
This person is not in the org chart
This person is not in any teams
This person is not in any offices